ENCrohn’s disease rarely takes anyone abroad in its first year: people travel when flares keep returning, drugs stop holding a remission or a surgeon proposes a resection and the patient wants to hear the alternatives. Crohn’s disease treatment in Germany is built not around one drug but around an exact map of where and how deeply the bowel is affected; everything else follows from it.
Below: tests, drugs and their order, when surgery makes sense, who leads care, costs and what to prepare. The disease is chronic and cannot yet be cured; the aim is a lasting remission, a long spell without inflammation. For an overview, see bowel treatment in Germany.
What Crohn’s Disease Is and How It Is Investigated
Crohn’s disease is a chronic inflammation that can affect any part of the digestive tract, most often the end of the small bowel and the start of the large bowel. Unlike ulcerative colitis, which inflames only the lining of the large bowel, it reaches deep into the wall, causing strictures (narrowings), fistulas and abscesses: hence pain, diarrhoea, weight loss and sometimes inflamed joints, eyes or skin. Its forms differ by location (end of the small bowel, both bowels, large bowel alone, called Crohn’s colitis, or rarely oesophagus and stomach) and by behaviour (inflammatory, stricturing or fistulising).
Before changing therapy, a German clinic starts with ileocolonoscopy, a colonoscopy that also examines the end of the small bowel, with biopsies from several segments. MR enterography (bowel MRI) and bowel ultrasound show the small bowel and fistulas, a stool test for calprotectin measures inflammation, and blood tests look for iron and vitamin B12 deficiency. Selected patients swallow a capsule camera.
Treatment is chosen by location, depth, fistulas and the course so far, as in the guideline of the German medical societies on the diagnosis and treatment of Crohn’s disease (in German), a living guideline of the German Society for Gastroenterology.
Drug Treatment and the Order It Follows
A flare is brought down with corticosteroids, which are not used long term: they do not maintain remission and cause serious side effects. So during the flare the doctor already decides what will hold the remission.
The main lines are immunosuppressants such as azathioprine and biologics, antibodies against single steps of inflammation: TNF blockers (infliximab, adalimumab), vedolizumab, an anti-integrin antibody acting mainly in the gut, and interleukin antibodies (ustekinumab, risankizumab); upadacitinib, a Janus kinase inhibitor, comes as tablets. These biologics and upadacitinib are authorised in the EU for Crohn’s disease. The treatment target is a healed bowel lining and falling calprotectin, not just feeling better, so therapy is reviewed against follow-up tests.
Accompanying measures often decide the outcome: correcting iron and vitamin deficiency, nutrition, pain management and stopping smoking, one of the few factors proven to affect the course (without cigarettes, flares return markedly less often). Finding the right drug can take months. There is no single «Crohn’s diet»: strictures call for less coarse fibre, flares for attention to lactose and fructose intolerance, and some patients, especially children, replace food with a liquid formula for several weeks. A dietitian plans the menu, as needless restrictions deepen deficiencies.
When Surgery Is Needed
Surgery in Crohn’s disease is not a defeat: it is done for drug-resistant strictures, fistulas, abscesses or obstruction, and when several drug lines have failed. The typical operation, an ileocaecal resection, removes the end of the small bowel with the start of the large bowel. In limited, recent disease unresponsive to steroids it is an equivalent alternative to infliximab.
In Germany such operations are preferably minimally invasive, and small-bowel strictures are widened by strictureplasty where possible, to preserve bowel length; surgeon and gastroenterologist manage the patient together before and after. Examples: Prof. Mia Kim, chief physician for visceral surgery and coloproctology at München Klinik Harlaching, whose focuses include minimally invasive treatment of Crohn’s disease and ulcerative colitis; Prof. Franz Bader, director of general, visceral and minimally invasive surgery at ISAR Klinikum in Munich, whose research covers both diseases; Prof. Ayman Agha, chief physician for visceral surgery at München Klinik Bogenhausen, whose focuses include minimally invasive surgery for both.
The honest caveat: surgery removes the affected segment, not the disease. Inflammation often returns near the join, though far from everyone gets symptoms again; a follow-up colonoscopy is done later, and patients at risk start maintenance therapy right after surgery. Better to know this beforehand.
Who Leads Such a Patient
Crohn’s disease needs a gastroenterologist focused on inflammatory bowel disease, not a general internist. Prof. Axel Dignass, for example, heads Medical Clinic I (gastroenterology, hepatology, oncology) at the Markus hospital of the AGAPLESION Frankfurter Diakonie Kliniken and is a co-author of the German Crohn’s disease guideline. Dr. René Pschowski heads internal medicine with gastroenterology at the DRK Kliniken Berlin and co-leads their inflammatory bowel disease centre. Prof. Roland Schmid directs Internal Medicine II at TUM Klinikum rechts der Isar in Munich, which has a university outpatient clinic for these diseases.
The team matters too: endoscopy, surgery, radiology, a rheumatologist and dermatologist when the disease goes beyond the bowel, and a dietitian. A second opinion on an existing regimen is normal, especially before switching a biologic or having surgery.
What the Cost of Crohn’s Disease Treatment in Germany Is Made Of
The clinic names the exact sum in its estimate after reviewing the documents; the bill covers consultations, investigations (ileocolonoscopy with histology, MR enterography, blood tests), inpatient days in a severe flare or around surgery, and the operation if needed.
The largest cost is long-term drug treatment: biologics are expensive and taken for a long time. So check before travelling how treatment continues at home: whether the drug is available locally, where infusions or injections are given, how often checks are needed and whether the German doctor can stay involved. The first trip’s estimate is not the cost of the whole treatment.
Frequently asked questions
Can Crohn’s disease be cured completely?
No. Crohn’s disease is chronic, and there is no way yet to get rid of it completely. The aim is a lasting steroid-free remission and a normal quality of life. Surgery does not cure it either: it removes a segment, not the disease, so follow-up continues.
Is a strict diet necessary with Crohn’s disease?
No single strict diet exists, and needless restrictions harm by deepening deficiencies. The menu changes with the situation: less coarse fibre with strictures, attention to lactose and fructose intolerance in a flare and, for some children, a liquid formula instead of food for several weeks.
How long does treatment in Germany take?
The investigation and case review usually fit into one trip, in which doctors clarify the form of the disease and propose a plan. Choosing the drug and judging the response take months and continue at home. Surgery adds inpatient days and recovery; the clinic plans the details after reviewing the documents.
How AlenMed Arranges Treatment
After a request, AlenMed has discharge summaries, colonoscopy and histology reports, MR images on disc and a dated drug list translated into German for the doctors (the tests are explained under digestive system diagnostics in Germany). The clinic replies with its proposal — a therapy review, further tests or surgery — and a cost estimate with the official visa invitation, recalculated if the findings change the plan.
AlenMed works with 86 partner hospitals in 38 cities and 345 doctors; the company office is in Munich. Departments with this focus exist nationwide, so the search follows the doctor and the free slot, not the city. A coordinator meets the patient, interprets at consultations and when results are discussed, and collects the discharge report with recommendations for further therapy.
This material is for information only and is not an offer. The treatment plan is set by a doctor at an in-person consultation.
News on this topic
Preventing Stomach Cancer Before It Starts: Breakthrough at Charité
Researchers at Charité have discovered how Helicobacter pylori reprograms stomach tissue, creating new possibilities for early molecular cancer prevention.
Approved Drug Shows Potential in Preventing Severe Pancreatitis
Researchers at Universitätsmedizin Greifswald showed that Anakinra can reduce tissue damage and scarring in acute and chronic pancreatitis.
